Company Filing History:
Years Active: 2001-2004
Title: Christopher M Clemens: Innovator in Chemical Agent Delivery
Introduction
Christopher M Clemens is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of chemical agent delivery, particularly in the context of interleukin-2 receptor-targeted therapies. With a total of 2 patents, his work has the potential to impact various medical applications.
Latest Patents
Clemens' latest patents focus on conjugates targeted to the interleukin-2 receptor. These compositions are designed for the intracellular delivery of chemical agents into interleukin-2-receptor-bearing cells, such as activated T cells. The innovative approach involves coupling a chemical agent with an interleukin-2-receptor-binding ligand that induces endocytosis. This method allows for the effective delivery of various chemical agents, including cytotoxins, gene regulators, and drugs. Additionally, the patents disclose methods for detecting diseases associated with elevated levels of soluble IL-2 receptor, such as T-cell lymphocytic leukemia and Hodgkin's disease.
Career Highlights
Throughout his career, Christopher M Clemens has worked with prominent companies in the pharmaceutical industry, including Watson Laboratories Inc. and Watson Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for medical challenges.
Collaborations
Clemens has collaborated with notable professionals in his field, including Ramesh K Prakash and Ramesh Prakash. These collaborations have likely enhanced his research and development efforts, leading to impactful innovations.
Conclusion
Christopher M Clemens is a distinguished inventor whose work in chemical agent delivery showcases his commitment to advancing medical science. His patents and career achievements reflect his significant contributions to the field.